Research Article| Volume 5, ISSUE 1, P42-47, February 2005

Scleroderma of the hand

      Scleroderma manifests itself in patterns ranging from localized to systemic types. Mainly the systemic type, called systemic sclerosis, involves the hand, leading to Raynaud’s phenomenon, ulcerations, arthropathies, and calcifications. Systemic sclerosis causes significant functional loss of the hand. Surgical intervention has been controversial because of anticipated wound healing problems arising from diminished blood circulation. Nevertheless, a surgical approach is indicated when conservative and pharmacologic treatment options fail. We review the literature and discuss the surgical techniques used for the most common manifestations of systemic sclerosis in the hand.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Hand Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Melvin J.L.
        Scleroderma (systemic sclerosis).
        in: Hunter J. Macklin E. Callahan A. Rehabilitation of the hand. Vol 2. Mosby, New York1995: 1385-1397
        • Cramer L.M.
        The management of the extravisceral manifestations of scleroderma.
        Plast Reconstr Surg. 1961; 28: 166-182
        • Nalebuff E.A.
        Surgery in patients with systemic sclerosis of the hand.
        Clin Orthop. 1999; 366: 91-97
        • Jones N.F.
        • Imbriglia J.E.
        • Steen V.D.
        • Medsger T.A.
        Surgery for scleroderma of the hand.
        J Hand Surg. 1987; 12A: 391-400
        • Goodfield M.J.D.
        • Hume A.
        • Rowell N.R.
        The effect of simple warming procedures on finger blood flow in systemic sclerosis.
        Br J Dermatol. 1988; 118: 661-668
        • Kristensen J.K.
        Blood flow and blood pressure in fingers in generalized scleroderma.
        Int J Dermatol. 1982; 21: 404-406
        • Seibold J.S.
        • Jagenau A.H.M.
        Treatment of Raynaud’s phenomenon with ketanserin, a selective antagonist of the serotonin 2 (5HT2) receptor.
        Arthritis Rheum. 1984; 27: 139-146
        • Jones N.F.
        • Raynor S.C.
        • Medsger T.A.
        Microsurgical revascularisation of the hand in scleroderma.
        Br J Plast Surg. 1987; 40: 264-269
        • Dabich L.
        • Bookstein J.J.
        • Zweifler A.
        • Zarafonetis C.J.D.
        Digital arteries in patients with scleroderma.
        Arch Intern Med. 1972; 130: 708-714
        • Haustein U.F.
        • Anderegg U.
        Pathophysiology of scleroderma.
        J Eur Acad Dermatol Venereol. 1998; 11: 1-8
        • Klein G.
        • Schneider G.
        Die arthropathia sclerodermica der hand und ihre differentialdiagnose gegenüber der progressiv chronischen polyarthritis.
        Wien Klin Wochenschr. 1972; 84: 27-29
        • Misra R.
        • Darton K.
        • Jewkes R.F.
        • Black C.M.
        • Maini R.N.
        Arthritis in scleroderma.
        Br J Rheumatol. 1995; 34: 831-837
        • Mittmann C.
        • Winckler S.
        Das Thibierge-Weissenbach syndrom.
        Chirurg. 1992; 63: 454-455
        • Mendelson B.C.
        • Linscheid R.L.
        • Dobyns J.H.
        • Muller S.A.
        Surgical treatment of calcinosis cutis in the upper extremity.
        J Hand Surg. 1977; 4: 318-324
        • Yoshida S.
        • Torikai K.
        The effects of warfarin on calcinosis in a patient with systemic sclerosis.
        J Rheumatol. 1993; 20: 1233-1235
        • Hurst L.N.
        • Evans H.B.
        • Brown D.H.
        Vasospasm control by intra-arterial reserpine.
        Plast Reconstr Surg. 1982; 70: 595-599
        • Rademaker M.
        • Cooke E.D.
        • Almond N.E.
        • et al.
        Comparison of intra venous infusions of iloprost and oral nifedipine in treatment of Raynaud phenomenon in patients with systemic sclerosis.
        BMJ. 1989; 298: 561-564
        • Barcroft H.
        • Walker A.J.
        Return of the tone in blood vessels of the upper limb after sympathectomy.
        Lancet. 1949; 1: 1035-1039
        • Flatt A.E.
        Digital artery sympathectomy.
        J Hand Surg. 1980; 5: 550-556
        • Pick J.
        The autonomic nervous system. J.B. Lippincott, Philadelphia1970
        • El-Gammal T.A.
        • Blair W.F.
        Digital periarterial sympathectomy for ischaemic digital pain and ulcers.
        J Hand Surg. 1991; 16B: 382-385
        • O’Brien M.C.
        • Kumar P.A.V.
        • Mellow C.G.
        • Oliver T.V.
        Radical microarteriolysis in the treatment of vasospastic disorders in the hand, especially scleroderma.
        J Hand Surg. 1992; 17B: 447-452
        • Tomaino M.M.
        Digital arterial occlusion in scleroderma.
        J Hand Surg. 2000; 25B: 611-613
        • Tomaino M.M.
        • Goitz R.J.
        • Medsger T.A.
        Surgery for ischemic pain and Raynaud’s’ phenomenon in scleroderma.
        Microsurgery. 2001; 21: 75-79
        • Hussmann J.
        • Russell R.C.
        • Kucan J.O.
        • Kardori R.
        • Steinau H.U.
        Soft tissue calcifications.
        Ann Plast Surg. 1995; 34: 138-147
        • Norris R.W.
        • Brown H.G.
        The proximal interphalangeal joint in systemic sclerosis and its surgical management.
        Br J Plast Surg. 1985; 38: 526-531
        • Askew L.J.
        • Beckett V.L.
        • An K.
        • Chao E.Y.S.
        Objective evaluation of hand function in scleroderma patients to assess effectiveness of physical therapy.
        Br J Rheum. 1983; 22: 224-232
        • Melvin J.L.
        Rheumatic disease in the adult and child. FA Davis, Philadelphia1987